AUG 25, 2015 5:10 PM PDT

Plant Extract Takes on MRSA

WRITTEN BY: Kerry Evans
Cassandra Quave, Ph.D., has built a career on the medicinal properties of plants.  The Emory University ethnobotanist is particularly interested in plant extracts that could be used to treat bacterial infections. Quave and University of Iowa microbiologist Alexander Horswill, Ph.D., identified chemicals from chestnut leaves (Castanea sativa) that decrease toxin production by methicillin-resistant Staphylococcus aureus (MRSA). 

Chestnut leaf extracts attenuate MRSA.
The team distilled chemicals from the chestnut leaves and identified 94 compounds that were active against the bacteria.  The chemicals, derivatives of ursene and oleanene, disrupt the agr pathway, a key quorum sensing pathway the bacteria use to communicate with each other and produce virulence factors such as toxins.  They published their findings in the journal PLOS ONE.

“Rather than killing Staph, this botanical extract works by taking away Staph’s weapons, essentially shutting off the ability of the bacteria to create toxins that cause tissue damage.  In other words, it takes the teeth out of the bacteria’s bite.”

The chestnut extract works by antagonizing the S. aureus “accessory gene regulator” (agr) system.  This system regulates virulence factor production through the quorum sensing molecule AIP.  An excess of AIP signals the bacteria to produce virulence factors such as toxins.

The extract cleared MRSA skin lesions in mice without affecting healthy tissue or normal skin flora.  Importantly, the bacteria did not become resistant to the extract, even after long-term exposure.

An obvious drawback is that these extracts do not actually kill the bacteria, they only attenuate virulence.  This means that antibiotics would need to be used in conjunction with the extracts, an obvious roadblock when treating antibiotic-resistant bacteria.

Despite this shortcoming, Quave is hopeful.  “We now have a mixture that works”, she says, “our goal is to further refine it into a simpler compound that would be eligible for FDA consideration as a therapeutic agent”.



Sources: PLOS ONE, Science Daily
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
NOV 27, 2019
Genetics & Genomics
NOV 27, 2019
Humans Are Continuing to Evolve, Along With Immune-Related Diseases
Humans have evolved in some ways to be less susceptible to pathogens, but those benefits can also carry risks of other diseases....
DEC 01, 2019
Genetics & Genomics
DEC 01, 2019
Engineering a Better Viral Delivery System for Gene Therapy
To send gene therapy to diseased cells, scientists have turned to adeno-associated viruses (AAVs) to act as a delivery system....
DEC 28, 2019
Microbiology
DEC 28, 2019
A DNA Star That Can Detect Dengue Virus
Like origami paper, DNA molecules can be folded and arranged into complex three-dimensional structures....
DEC 29, 2019
Microbiology
DEC 29, 2019
Coral Reef-Building Organisms Capture First Place in Small World Competition
The winner of the Nikon Small World in Motion contest has captured a tiny animal called coral polyp as light levels go down and it emerges....
JAN 02, 2020
Microbiology
JAN 02, 2020
New Ideas About How Bacteria Control Cell Division
Cell division is a crucial process for life; in order to create and maintain multicellular organisms, cells have to make more cells by dividing....
JAN 09, 2020
Cell & Molecular Biology
JAN 09, 2020
Acidic Stomach Environment May Worsen Microbial Pathogenicity
The acids of the stomach may not pose a problem for bad bugs....
Loading Comments...